The nanoB2A Group

The nanoB2A Group focuses on the development of photonic and nanomechanical nanobiosensor devices of high sensitivity for label-free detection; biofunctionalization of surfaces; and the integration in lab-on-a-chip microsystems for real field diagnostics applications.

What We Do

We develop biosensors based on plasmonics, evanescent wave sensing and on nanomechanical changes, with high sensitivity and selectivity.

Bioanalytical Aplications

The Bioanalytical Applications research activities cover the detection of a wide range of molecules, of high interest in diverse fields as clinical diagnostic, environmental control, genomic and proteomic, under laboratory and real conditions and using the biosensor devices developed within the Group.

Early Detection of Diseases and Pathogens

Integration of multibiosensor arrays on Lab-on-a-chip platforms will allow the early detection of diseases and pathogens (in vitro and in-vivo).

Lab Gallery

Lab Gallery

Setup Gallery

Setup Gallery

Devices Gallery

DevicesGallery

News

Molecular inversion probe-based SPR biosensing for specific, label-free and real-time detection of regional DNA methylation

Highly Sensitive Dendrimer-based Nanoplasmonic Biosensor for Drug Allergy Diagnosis

Substrate E ff ect on the Refractive Index Sensitivity of Silver Nanoparticles

Invited presentation at “Segundas Jornadas de Actualización sobre Tuberculosis en España”

October 17. Consejo General de Colegios Oficiales de Médicos en España (CGCOM), Madrid. Conference focused on the advances in the prevention and control of Tuberculosis, sponsored by the “Red contra la Tuberculosis y por la Solidaridad, Red TBS”.Dr. Ana Belén González will deliver the presentation titled: “Nuevas tecnologías de diagnóstico: Proyecto Pocket”.